Report Detail

Other Global Pharmaceutical Regulatory Affairs Market Size, Status and Forecast 2020-2026

  • RnM4275633
  • |
  • 31 December, 2020
  • |
  • Global
  • |
  • 134 Pages
  • |
  • QYResearch
  • |
  • Other

1 Report Overview

  • 1.1 Study Scope
  • 1.2 Key Market Segments
  • 1.3 Market Analysis by Type
    • 1.3.1 Global Pharmaceutical Regulatory Affairs Market Size Growth Rate by Type: 2020 VS 2026
    • 1.3.2 Regulatory Consulting
    • 1.3.3 Legal Representation
    • 1.3.4 Regulatory Writing & Publishing
    • 1.3.5 Product Registration & Clinical Trial Application
    • 1.3.6 Other Services
  • 1.4 Market by Application
    • 1.4.1 Global Pharmaceutical Regulatory Affairs Market Share by Application: 2020 VS 2026
    • 1.4.2 In-house
    • 1.4.3 Outsourcing
  • 1.5 Study Objectives
  • 1.6 Years Considered

2 Global Growth Trends

  • 2.1 Global Pharmaceutical Regulatory Affairs Market Perspective (2015-2026)
  • 2.2 Pharmaceutical Regulatory Affairs Growth Trends by Regions
    • 2.2.1 Pharmaceutical Regulatory Affairs Market Size by Regions: 2015 VS 2020 VS 2026
    • 2.2.2 Pharmaceutical Regulatory Affairs Historic Market Share by Regions (2015-2020)
    • 2.2.3 Pharmaceutical Regulatory Affairs Forecasted Market Size by Regions (2021-2026)
  • 2.3 Pharmaceutical Regulatory Affairs Industry Dynamic
    • 2.3.1 Pharmaceutical Regulatory Affairs Market Trends
    • 2.3.2 Pharmaceutical Regulatory Affairs Market Drivers
    • 2.3.3 Pharmaceutical Regulatory Affairs Market Challenges
    • 2.3.4 Pharmaceutical Regulatory Affairs Market Restraints

3 Competition Landscape by Key Players

  • 3.1 Global Top Pharmaceutical Regulatory Affairs Players by Market Size
    • 3.1.1 Global Top Pharmaceutical Regulatory Affairs Players by Revenue (2015-2020)
    • 3.1.2 Global Pharmaceutical Regulatory Affairs Revenue Market Share by Players (2015-2020)
  • 3.2 Global Pharmaceutical Regulatory Affairs Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
  • 3.3 Players Covered: Ranking by Pharmaceutical Regulatory Affairs Revenue
  • 3.4 Global Pharmaceutical Regulatory Affairs Market Concentration Ratio
    • 3.4.1 Global Pharmaceutical Regulatory Affairs Market Concentration Ratio (CR5 and HHI)
    • 3.4.2 Global Top 10 and Top 5 Companies by Pharmaceutical Regulatory Affairs Revenue in 2019
  • 3.5 Key Players Pharmaceutical Regulatory Affairs Area Served
  • 3.6 Key Players Pharmaceutical Regulatory Affairs Product Solution and Service
  • 3.7 Date of Enter into Pharmaceutical Regulatory Affairs Market
  • 3.8 Mergers & Acquisitions, Expansion Plans

4 Pharmaceutical Regulatory Affairs Breakdown Data by Type

  • 4.1 Global Pharmaceutical Regulatory Affairs Historic Market Size by Type (2015-2020)
  • 4.2 Global Pharmaceutical Regulatory Affairs Forecasted Market Size by Type (2021-2026)

5 Pharmaceutical Regulatory Affairs Breakdown Data by Application

  • 5.1 Global Pharmaceutical Regulatory Affairs Historic Market Size by Application (2015-2020)
  • 5.2 Global Pharmaceutical Regulatory Affairs Forecasted Market Size by Application (2021-2026)

6 North America

  • 6.1 North America Pharmaceutical Regulatory Affairs Market Size (2015-2026)
  • 6.2 North America Pharmaceutical Regulatory Affairs Market Size by Type (2015-2020)
  • 6.3 North America Pharmaceutical Regulatory Affairs Market Size by Application (2015-2020)
  • 6.4 North America Pharmaceutical Regulatory Affairs Market Size by Country (2015-2020)
    • 6.4.1 United States
    • 6.4.2 Canada

7 Europe

  • 7.1 Europe Pharmaceutical Regulatory Affairs Market Size (2015-2026)
  • 7.2 Europe Pharmaceutical Regulatory Affairs Market Size by Type (2015-2020)
  • 7.3 Europe Pharmaceutical Regulatory Affairs Market Size by Application (2015-2020)
  • 7.4 Europe Pharmaceutical Regulatory Affairs Market Size by Country (2015-2020)
    • 7.4.1 Germany
    • 7.4.2 France
    • 7.4.3 U.K.
    • 7.4.4 Italy
    • 7.4.5 Russia
    • 7.4.6 Nordic

8 Asia-Pacific

  • 8.1 Asia-Pacific Pharmaceutical Regulatory Affairs Market Size (2015-2026)
  • 8.2 Asia-Pacific Pharmaceutical Regulatory Affairs Market Size by Type (2015-2020)
  • 8.3 Asia-Pacific Pharmaceutical Regulatory Affairs Market Size by Application (2015-2020)
  • 8.4 Asia-Pacific Pharmaceutical Regulatory Affairs Market Size by Region (2015-2020)
    • 8.4.1 China
    • 8.4.2 Japan
    • 8.4.3 South Korea
    • 8.4.4 Southeast Asia
    • 8.4.5 India
    • 8.4.6 Australia

9 Latin America

  • 9.1 Latin America Pharmaceutical Regulatory Affairs Market Size (2015-2026)
  • 9.2 Latin America Pharmaceutical Regulatory Affairs Market Size by Type (2015-2020)
  • 9.3 Latin America Pharmaceutical Regulatory Affairs Market Size by Application (2015-2020)
  • 9.4 Latin America Pharmaceutical Regulatory Affairs Market Size by Country (2015-2020)
    • 9.4.1 Mexico
    • 9.4.2 Brazil

10 Middle East & Africa

  • 10.1 Middle East & Africa Pharmaceutical Regulatory Affairs Market Size (2015-2026)
  • 10.2 Middle East & Africa Pharmaceutical Regulatory Affairs Market Size by Type (2015-2020)
  • 10.3 Middle East & Africa Pharmaceutical Regulatory Affairs Market Size by Application (2015-2020)
  • 10.4 Middle East & Africa Pharmaceutical Regulatory Affairs Market Size by Country (2015-2020)
    • 10.4.1 Turkey
    • 10.4.2 Saudi Arabia
    • 10.4.3 UAE

11Key Players Profiles

  • 11.1 QuintilesIMS
    • 11.1.1 QuintilesIMS Company Details
    • 11.1.2 QuintilesIMS Business Overview
    • 11.1.3 QuintilesIMS Pharmaceutical Regulatory Affairs Introduction
    • 11.1.4 QuintilesIMS Revenue in Pharmaceutical Regulatory Affairs Business (2015-2020))
    • 11.1.5 QuintilesIMS Recent Development
  • 11.2 LabCor
    • 11.2.1 LabCor Company Details
    • 11.2.2 LabCor Business Overview
    • 11.2.3 LabCor Pharmaceutical Regulatory Affairs Introduction
    • 11.2.4 LabCor Revenue in Pharmaceutical Regulatory Affairs Business (2015-2020)
    • 11.2.5 LabCor Recent Development
  • 11.3 PAREXEL
    • 11.3.1 PAREXEL Company Details
    • 11.3.2 PAREXEL Business Overview
    • 11.3.3 PAREXEL Pharmaceutical Regulatory Affairs Introduction
    • 11.3.4 PAREXEL Revenue in Pharmaceutical Regulatory Affairs Business (2015-2020)
    • 11.3.5 PAREXEL Recent Development
  • 11.4 Pharmaceutical Product Development
    • 11.4.1 Pharmaceutical Product Development Company Details
    • 11.4.2 Pharmaceutical Product Development Business Overview
    • 11.4.3 Pharmaceutical Product Development Pharmaceutical Regulatory Affairs Introduction
    • 11.4.4 Pharmaceutical Product Development Revenue in Pharmaceutical Regulatory Affairs Business (2015-2020)
    • 11.4.5 Pharmaceutical Product Development Recent Development
  • 11.5 INC RESEARCH HOLDINGS
    • 11.5.1 INC RESEARCH HOLDINGS Company Details
    • 11.5.2 INC RESEARCH HOLDINGS Business Overview
    • 11.5.3 INC RESEARCH HOLDINGS Pharmaceutical Regulatory Affairs Introduction
    • 11.5.4 INC RESEARCH HOLDINGS Revenue in Pharmaceutical Regulatory Affairs Business (2015-2020)
    • 11.5.5 INC RESEARCH HOLDINGS Recent Development
  • 11.6 PRA Health Sciences
    • 11.6.1 PRA Health Sciences Company Details
    • 11.6.2 PRA Health Sciences Business Overview
    • 11.6.3 PRA Health Sciences Pharmaceutical Regulatory Affairs Introduction
    • 11.6.4 PRA Health Sciences Revenue in Pharmaceutical Regulatory Affairs Business (2015-2020)
    • 11.6.5 PRA Health Sciences Recent Development
  • 11.7 ICON
    • 11.7.1 ICON Company Details
    • 11.7.2 ICON Business Overview
    • 11.7.3 ICON Pharmaceutical Regulatory Affairs Introduction
    • 11.7.4 ICON Revenue in Pharmaceutical Regulatory Affairs Business (2015-2020)
    • 11.7.5 ICON Recent Development
  • 11.8 Charles River
    • 11.8.1 Charles River Company Details
    • 11.8.2 Charles River Business Overview
    • 11.8.3 Charles River Pharmaceutical Regulatory Affairs Introduction
    • 11.8.4 Charles River Revenue in Pharmaceutical Regulatory Affairs Business (2015-2020)
    • 11.8.5 Charles River Recent Development
  • 11.9 Advent International
    • 11.9.1 Advent International Company Details
    • 11.9.2 Advent International Business Overview
    • 11.9.3 Advent International Pharmaceutical Regulatory Affairs Introduction
    • 11.9.4 Advent International Revenue in Pharmaceutical Regulatory Affairs Business (2015-2020)
    • 11.9.5 Advent International Recent Development
  • 11.10 WuXi AppTec, Inc.
    • 11.10.1 WuXi AppTec, Inc. Company Details
    • 11.10.2 WuXi AppTec, Inc. Business Overview
    • 11.10.3 WuXi AppTec, Inc. Pharmaceutical Regulatory Affairs Introduction
    • 11.10.4 WuXi AppTec, Inc. Revenue in Pharmaceutical Regulatory Affairs Business (2015-2020)
    • 11.10.5 WuXi AppTec, Inc. Recent Development
  • 11.11 Pharmaron Beijing Co., Ltd.
    • 10.11.1 Pharmaron Beijing Co., Ltd. Company Details
    • 10.11.2 Pharmaron Beijing Co., Ltd. Business Overview
    • 10.11.3 Pharmaron Beijing Co., Ltd. Pharmaceutical Regulatory Affairs Introduction
    • 10.11.4 Pharmaron Beijing Co., Ltd. Revenue in Pharmaceutical Regulatory Affairs Business (2015-2020)
    • 10.11.5 Pharmaron Beijing Co., Ltd. Recent Development
  • 11.12 Hangzhou Tigermed Consulting Co.,Ltd.
    • 10.12.1 Hangzhou Tigermed Consulting Co.,Ltd. Company Details
    • 10.12.2 Hangzhou Tigermed Consulting Co.,Ltd. Business Overview
    • 10.12.3 Hangzhou Tigermed Consulting Co.,Ltd. Pharmaceutical Regulatory Affairs Introduction
    • 10.12.4 Hangzhou Tigermed Consulting Co.,Ltd. Revenue in Pharmaceutical Regulatory Affairs Business (2015-2020)
    • 10.12.5 Hangzhou Tigermed Consulting Co.,Ltd. Recent Development
  • 11.13 Asymchem Laboratories (Tianjin) Co.,Ltd.
    • 10.13.1 Asymchem Laboratories (Tianjin) Co.,Ltd. Company Details
    • 10.13.2 Asymchem Laboratories (Tianjin) Co.,Ltd. Business Overview
    • 10.13.3 Asymchem Laboratories (Tianjin) Co.,Ltd. Pharmaceutical Regulatory Affairs Introduction
    • 10.13.4 Asymchem Laboratories (Tianjin) Co.,Ltd. Revenue in Pharmaceutical Regulatory Affairs Business (2015-2020)
    • 10.13.5 Asymchem Laboratories (Tianjin) Co.,Ltd. Recent Development
  • 11.14 Accell Clinical Research, LLC.
    • 10.14.1 Accell Clinical Research, LLC. Company Details
    • 10.14.2 Accell Clinical Research, LLC. Business Overview
    • 10.14.3 Accell Clinical Research, LLC. Pharmaceutical Regulatory Affairs Introduction
    • 10.14.4 Accell Clinical Research, LLC. Revenue in Pharmaceutical Regulatory Affairs Business (2015-2020)
    • 10.14.5 Accell Clinical Research, LLC. Recent Development
  • 11.15 GenPact Ltd.
    • 10.15.1 GenPact Ltd. Company Details
    • 10.15.2 GenPact Ltd. Business Overview
    • 10.15.3 GenPact Ltd. Pharmaceutical Regulatory Affairs Introduction
    • 10.15.4 GenPact Ltd. Revenue in Pharmaceutical Regulatory Affairs Business (2015-2020)
    • 10.15.5 GenPact Ltd. Recent Development
  • 11.16 Criterium, Inc.
    • 10.16.1 Criterium, Inc. Company Details
    • 10.16.2 Criterium, Inc. Business Overview
    • 10.16.3 Criterium, Inc. Pharmaceutical Regulatory Affairs Introduction
    • 10.16.4 Criterium, Inc. Revenue in Pharmaceutical Regulatory Affairs Business (2015-2020)
    • 10.16.5 Criterium, Inc. Recent Development
  • 11.17 Promedica International
    • 10.17.1 Promedica International Company Details
    • 10.17.2 Promedica International Business Overview
    • 10.17.3 Promedica International Pharmaceutical Regulatory Affairs Introduction
    • 10.17.4 Promedica International Revenue in Pharmaceutical Regulatory Affairs Business (2015-2020)
    • 10.17.5 Promedica International Recent Development
  • 11.18 Medpace
    • 10.18.1 Medpace Company Details
    • 10.18.2 Medpace Business Overview
    • 10.18.3 Medpace Pharmaceutical Regulatory Affairs Introduction
    • 10.18.4 Medpace Revenue in Pharmaceutical Regulatory Affairs Business (2015-2020)
    • 10.18.5 Medpace Recent Development
  • 11.19 Covance
    • 10.19.1 Covance Company Details
    • 10.19.2 Covance Business Overview
    • 10.19.3 Covance Pharmaceutical Regulatory Affairs Introduction
    • 10.19.4 Covance Revenue in Pharmaceutical Regulatory Affairs Business (2015-2020)
    • 10.19.5 Covance Recent Development
  • 11.20 Freyr
    • 10.20.1 Freyr Company Details
    • 10.20.2 Freyr Business Overview
    • 10.20.3 Freyr Pharmaceutical Regulatory Affairs Introduction
    • 10.20.4 Freyr Revenue in Pharmaceutical Regulatory Affairs Business (2015-2020)
    • 10.20.5 Freyr Recent Development

12Analyst's Viewpoints/Conclusions

    13Appendix

    • 13.1 Research Methodology
      • 13.1.1 Methodology/Research Approach
      • 13.1.2 Data Source
    • 13.2 Disclaimer

    Pharmaceutical Regulatory Affairs market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Pharmaceutical Regulatory Affairs market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026.

    Market segment by Type, the product can be split into
    Regulatory Consulting
    Legal Representation
    Regulatory Writing & Publishing
    Product Registration & Clinical Trial Application
    Other Services

    Market segment by Application, split into
    In-house
    Outsourcing

    Based on regional and country-level analysis, the Pharmaceutical Regulatory Affairs market has been segmented as follows:
    North America
    United States
    Canada
    Europe
    Germany
    France
    U.K.
    Italy
    Russia
    Nordic
    Asia-Pacific
    China
    Japan
    South Korea
    Southeast Asia
    India
    Australia
    Latin America
    Mexico
    Brazil
    Middle East & Africa
    Turkey
    Saudi Arabia
    UAE

    In the competitive analysis section of the report, leading as well as prominent players of the global Pharmaceutical Regulatory Affairs market are broadly studied on the basis of key factors. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on price and revenue (global level) by player for the period 2015-2020.
    The key players covered in this study
    QuintilesIMS
    LabCor
    PAREXEL
    Pharmaceutical Product Development
    INC RESEARCH HOLDINGS
    PRA Health Sciences
    ICON
    Charles River
    Advent International
    WuXi AppTec, Inc.
    Pharmaron Beijing Co., Ltd.
    Hangzhou Tigermed Consulting Co.,Ltd.
    Asymchem Laboratories (Tianjin) Co.,Ltd.
    Accell Clinical Research, LLC.
    GenPact Ltd.
    Criterium, Inc.
    Promedica International
    Medpace
    Covance


    Summary:
    Get latest Market Research Reports on Pharmaceutical Regulatory Affairs. Industry analysis & Market Report on Pharmaceutical Regulatory Affairs is a syndicated market report, published as Global Pharmaceutical Regulatory Affairs Market Size, Status and Forecast 2020-2026. It is complete Research Study and Industry Analysis of Pharmaceutical Regulatory Affairs market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.

    Last updated on

    REPORT YOU MIGHT BE INTERESTED

    Purchase this Report

    $3,900.00
    $5,850.00
    $7,800.00
    2,848.64
    4,272.96
    5,697.28
    3,202.66
    4,803.98
    6,405.31
    404,613.30
    606,919.95
    809,226.60
    284,730.42
    427,095.63
    569,460.84
    Credit card Logo

    Related Reports


    Reason to Buy

    Request for Sample of this report